705 related articles for article (PubMed ID: 28052758)
21. Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
Ryoo BY; Merle P; Kulkarni AS; Cheng AL; Bouattour M; Lim HY; Breder V; Edeline J; Chao Y; Ogasawara S; Yau T; Garrido M; Chan SL; Daniele B; Norquist JM; Chen E; Siegel AB; Zhu AX; Finn RS; Kudo M
Cancer; 2021 Mar; 127(6):865-874. PubMed ID: 33231873
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life among prostate cancer patients: real-life situation at the beginning of treatment.
Bergius S; Torvinen S; Muhonen T; Roine RP; Sintonen H; Taari K
Scand J Urol; 2017 Feb; 51(1):13-19. PubMed ID: 27809631
[TBL] [Abstract][Full Text] [Related]
23. Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.
Diouf M; Bonnetain F; Barbare JC; Bouché O; Dahan L; Paoletti X; Filleron T
Oncologist; 2015 Jan; 20(1):62-71. PubMed ID: 25542450
[TBL] [Abstract][Full Text] [Related]
24. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.
Yeo W; Mo FK; Koh J; Chan AT; Leung T; Hui P; Chan L; Tang A; Lee JJ; Mok TS; Lai PB; Johnson PJ; Zee B
Ann Oncol; 2006 Jul; 17(7):1083-9. PubMed ID: 16600982
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of the Simplified Chinese Version of EORTC QLQ-HCC18 for Patients with Hepatocellular Carcinoma.
Yang Z; Wan C; Li W; Cun Y; Meng Q; Ding Y; Chen P
Cancer Invest; 2015; 33(8):340-6. PubMed ID: 26046473
[TBL] [Abstract][Full Text] [Related]
26. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
27. Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30.
Phillips R; Gandhi M; Cheung YB; Findlay MP; Win KM; Hai HH; Yang JM; Lobo RR; Soo KC; Chow PK
J Clin Epidemiol; 2015 Aug; 68(8):895-902. PubMed ID: 25843232
[TBL] [Abstract][Full Text] [Related]
28. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.
Beisland E; Aarstad HJ; Aarstad AK; Bakke A; Bostad L; Beisland C
Acta Oncol; 2016; 55(3):349-56. PubMed ID: 26251300
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy.
Meyer F; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B; Bairati I
J Clin Oncol; 2009 Jun; 27(18):2970-6. PubMed ID: 19451440
[TBL] [Abstract][Full Text] [Related]
30. Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC.
Hartrumpf KJ; Marquardt S; Werncke T; Murray T; Kirstein MM; Vogel A; Wacker F; Rodt T
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1991-1999. PubMed ID: 30008024
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
Anker MS; Potthoff SK; Lena A; Porthun J; Hadzibegovic S; Evertz R; Denecke C; Fröhlich AK; Sonntag F; Regitz-Zagrosek V; Rosen SD; Lyon AR; Lüscher TF; Spertus JA; Anker SD; Karakas M; Bullinger L; Keller U; Landmesser U; Butler J; von Haehling S
Eur J Heart Fail; 2023 Sep; 25(9):1635-1647. PubMed ID: 37369985
[TBL] [Abstract][Full Text] [Related]
32. Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Klein J; Dawson LA; Jiang H; Kim J; Dinniwell R; Brierley J; Wong R; Lockwood G; Ringash J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):16-25. PubMed ID: 26279020
[TBL] [Abstract][Full Text] [Related]
33. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
Miret C; Orive M; Sala M; García-Gutiérrez S; Sarasqueta C; Legarreta MJ; Redondo M; Rivero A; Castells X; Quintana JM; Garin O; Ferrer M;
Qual Life Res; 2023 Apr; 32(4):989-1003. PubMed ID: 36630024
[TBL] [Abstract][Full Text] [Related]
34. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials.
Ediebah DE; Quinten C; Coens C; Ringash J; Dancey J; Zikos E; Gotay C; Brundage M; Tu D; Flechtner HH; Greimel E; Reeve BB; Taphoorn M; Reijneveld J; Dirven L; Bottomley A;
Cancer; 2018 Aug; 124(16):3409-3416. PubMed ID: 29905936
[TBL] [Abstract][Full Text] [Related]
35. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
[TBL] [Abstract][Full Text] [Related]
36. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study.
van Kleef JJ; Dijksterhuis WPM; van den Boorn HG; Prins M; Verhoeven RHA; Gisbertz SS; Slingerland M; Mohammad NH; Creemers GJ; Neelis KJ; Heisterkamp J; Rosman C; Ruurda JP; Kouwenhoven EA; van de Poll-Franse LV; van Oijen MGH; Sprangers MAG; van Laarhoven HWM;
Gastric Cancer; 2021 Nov; 24(6):1203-1212. PubMed ID: 34251543
[TBL] [Abstract][Full Text] [Related]
38. General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.
Pilz MJ; Loth FLC; Nolte S; Thurner AMM; Gamper EM; Anota A; Liegl G; Giesinger JM;
J Patient Rep Outcomes; 2024 May; 8(1):48. PubMed ID: 38695992
[TBL] [Abstract][Full Text] [Related]
39. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Sibhat SG; Fenta TG; Sander B; Gebretekle GB
Health Qual Life Outcomes; 2019 Nov; 17(1):165. PubMed ID: 31690327
[TBL] [Abstract][Full Text] [Related]
40. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
de Ligt KM; Aaronson NK; Liegl G; Nolte S;
Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
